Roger Fleischman is an Oncology physician affiliated with University of Kentucky. OpenAlex indexes 40 publications with 1,613 citations (h-index 20).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
800 Rose Street Cc180a Roach Bldg.
Uk Hematology Clinic
Lexington, KY 405360093
Telephone
859-257-6006Registry record last updated 17 Sept 2014.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SERVIER PHARMACEUTICALS LLCProgram year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- E.R. Squibb & Sons, L.L.C.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
91.6%Kinase inhibitor87%Calquence46%Imbruvica17%Jaypirca8%Tasigna8%Brukinsa8%Gleevec6%Imatinib Mesylate6%Part D<11 patientsBCR-ABL tyrosine kinase inhibitors4.6%Scemblix100%Part D<11 patientsMetabolism & gastrointestinal
8.4%Corticosteroid8.4%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Interleukin-10 suppression enhances T-cell antitumor immunity and responses to checkpoint blockade in chronic lymphocytic leukemia
bioRxiv (Cold Spring Harbor Laboratory)
2020 - CGE19-065: Number of Somatic Mutations Is an Independent Predictor of Overall Survival in Acute Myeloid Leukemia
Journal of the National Comprehensive Cancer Network
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Kenneth Ain, MD
University of Kentucky
Zhonglin Hao, MD, PhD
University of Kentucky
David Mannino, MD
University of Kentucky
David Moliterno, MD
University of Kentucky
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”